The Double Marker Test offered by Redcliffe Labs is a crucial prenatal screening test conducted during the first trimester of pregnancy. It helps assess the risk of chromosomal abnormalities in the fetus, such as Down syndrome (Trisomy 21) and Trisomy 18. This blood test measures two key markers—Free Beta hCG and PAPP-A (Pregnancy Associated Plasma Protein A)—and is often combined with an ultrasound scan (NT scan) for enhanced accuracy. It is typically recommended between the 9th and 13th week of pregnancy. The Double Marker Test does not diagnose a condition but indicates whether further diagnostic tests may be needed. With accurate analysis, timely reporting, and expert consultation, Redcliffe Labs ensures expectant mothers receive the information and support they need for a healthy pregnancy journey.
